Delivery Order SPE2DB22D3016-SPE2DB25FALL8

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Remifentanil 1 mg vials, a specialty medication. The fixed-price delivery order has a ceiling value of $3,632.56 and a completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,239.30 Firm Fixed Price Delivery Order covers the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REMIFENTANIL 1 MG VIALS. The delivery order contract, valued at $5,149.43, has a firm fixed price and is set to expire on October 22, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,448.90 firm fixed-price delivery order is for the supply of 2 mg Remifentanil vials, a specialty medication used for pain management. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of REMIFENTANIL 1 MG VIALS. The $2,686.05 firm-fixed-price delivery order has a completion date of December 6, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,667.20 firm fixed-price delivery order is for the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,063.41 for the supply of REMIFENTANIL 1 MG VIALS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 22, 2024. The contract is a Firm Fixed Price arrangement, and no set-aside designation was used. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $18,162.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract is a Firm Fixed Price Delivery Order with a completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $12,289.20 for the supply of 1 mg vials of the medication remifentanil. The award has no set-aside designation and an ultimate completion date of October 11, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,632.56, is a Firm Fixed Price Delivery Order for the provision of REMIFENTANIL 1 MG VIALS. No set-aside designation was used for this award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FALL8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,881.58, is a Firm Fixed Price Delivery Order for the supply of 2 mg vials of the drug Remifentanil. The contract has a period of performance through January 29, 2025 and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 9:57 AM